SUMMARY A highly sensitive fluorimetric assay for the measurement of pyridoxal and pyridoxal phosphate in biological tissues is described. The method involves the enzymic hydrolysis of pyridoxal phosphate to pyridoxal. The pyridoxal (free or total) is separated on an anion-exchange column, concentrated by cation-exchange chromatography and reacted with potassium cyanide under slightly alkaline conditions to form 4-pyridoxolactone, a highly fluorescent compound. The method is applied to the measurement of pyridoxal, pyridoxal phosphate and total pyridoxal in plasma and neutrophils from control subjects and patients with sideroblastic marrow and identified the patient with pyridoxine-responsive sideroblastic anaemia.
Pyridoxal 5'-phosphate, the coenzyme form of pyridoxine (vitamin B6) plays an important role in numerous biochemical reactions. The pyridoxal content of tissues is regulated by a number of factors including plasma membrane transport,' phosphorylation of free pyridoxal2 and by binding of the coenzyme to apoprotein.34 Pyridoxal phosphate concentrations are controlled by pyridoxal phosphate phosphataseSS 6 17 January 1983 pyridoxal phosphate in biological samples is the microbiological assay method using Lactobacillus casei. 16 Although the method is highly sensitive, it is very time-consuming and requires specialised expertise and equipment not available to the majority of laboratories.
This paper presents a sensitive fluorimetric assay for the estimation of pyridoxal and pyridoxal phosphate in biological samples. The assay is based on hydrolysis of pyridoxal phosphate by acid phosphatase followed by ion-exchange chromatography and oxidation of the pyridoxal to fluorescent 4-pyridoxolactone. added and the samples treated exactly as for the estimation of free pyridoxal. The difference between total and free pyridoxal was pyridoxal phosphate.
Fluorimetric determination ofpyridoxal in tissue extracts
The procedure for the measurement of pyridoxal in tissue extracts is outlined in Fig. 1 . A previously prepared 5 cm anion-exchange column was mounted above each cation-exchange column so that the effluent from the first column ran directly onto the second column. An extract of plasma or neutrophils, 3 ml, was loaded onto the anion exchange column and eluted with 2 ml 0-2 M Na acetate buffer, pH 4-0. The eluent from the first column then passed directly onto the cationexchange column. At this stage the first column was removed and discarded and the cation-exchange column eluted sequentially with 4i5 ml distilled water and with two portions of 1-5 ml 20 mmol Tris-HCl containing 0-1 M KCI, pH 9-0 (elution buffer). The second 1-5 ml eluate was retained for analysis. To the standards and unknown samples of pyridoxal (0-025-1-0 nmol in 1*5 ml elution buffer) were added 0O2 M Tris-HCl, pH 7-5 (0.5 ml) and O-1 M KCN in 0-1 M Tris-HCl, pH 7-5 (0-05 ml). After thorough mixing, the tubes were heated in the dark for 2 h at 50°C in a Tecam dry bath. After cooling, 0*4 M Na2CO, ( the pH of the eluent measured. All columns less than 4 cm in length failed to remove the trichloroacetic acid and the pH of the effluents remained less than 4-0. A 5 cm column removed all trichloroacetic acid from the sample and the effluent (pH 4-0) was suitable for direct loading onto the cation exchange column.
Cation-exchange column
Under the conditions of assay pyridoxal forms a highly fluorescent product when oxidised with alkaline potassium cyanide. Unfortunately, pyridoxal phosphate, under the same conditions, also gives rise to a fluorescent product with an emission intensity one-sixth of that produced by pyridoxal. Therefore, in order to accurately assay pyridoxal a separation procedure was required. At pH 4-0 pyridoxal binds to the cation exchange resin whilst pyridoxal phosphate does not. The UVvisible spectra of a typical elution are shown in Fig.  5 . All (99%) the pyridoxal was eluted in the second 1.5 ml of elution buffer with no further material present in the subsequent 1-5 ml of elution buffer. The recovery of pyridoxal over the entire procedure was 98-105%. There was no increase in recovery of pyridoxal after the addition of pyridoxal phosphate at the fluorescent step. Control subjects 14 ± 9-6 5-60 + 67 20-0 ± 6-6 7-6 ± 2-5 13-4 + 81 20-6 ± 8-6 (mean ± SD) (5) Concentrations in plasma are expressed as pmol/ml and in neutrophils as pmol/mg protein.
Discussion
The 
